Endeavor Vision, Senior Investment Director
Alexander Schmitz is a Senior Investment Director at Endeavour Vision, focusing on medical technology and digital health investments. He represents Endeavour Vision on the boards of Endostim and Vertiflex, and serves as a board observer at Gynesonics. Alex also serves as a member of the steering committee for PCR Innovators Day.
Alex has more than two decades of business and strategy experience in both medical device and high-technology companies. From 2005 to 2014, he helped Biosensors International Group develop its interventional cardiology business, from less than $5 million in annual revenues to more than $300 million. Serving as vice president of business development, he played a key role in establishing and building the company’s presence across Europe and Asia.
Prior to Biosensors, Alex spent three years with LogiSpring, the corporate venture fund of the TNT Post Group, advising on investments enabling supply chain and industrial automation applications. He also previously worked for MicroStrategy, a leading provider of business intelligence software, helping clients in the financial services industry develop and deploy complex risk management and financial information systems.
Alex began his career as a management consultant with McKinsey & Company, where in addition to serving clients in the aerospace and telecommunications industries, he also spent a year with the McKinsey Global Institute based in Washington, D.C. and Seoul, South Korea.
Alex holds an MBA from INSEAD and a BSFS, magna cum laude, from Georgetown University’s School of Foreign Service, where he was a Krogh Scholar.